Olitigaltin

DB12895InvestigationalSmall molecule

Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

Mechanism: Pharmacologically active on Galectin-3
Curator reviewed
Formula / weight: C₂₈H₃₀F₂N₆O₈S · 648.64 g/mol (avg)
Also known as: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfane
Code names: GB-0139 · TD-139

Resolves to

Compound

Structure

OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@@H]([C@H]2O)N2C=C(N=N2)C2=CC=CC(F)=C2)[C@H](O)[C@H]([C@H]1O)N1C=C(N=N1)C1=CC(F)=CC=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Olitigaltin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.